OUR TECHNOLOGY
Our technology combines custom 128-gene panels with real-time mRNA expression analysis to deliver early, accurate, and actionable disease diagnosis
Scroll Down to Know More
TARGETED. ACTIONABLE.
DESIGNED FOR EARLY DETECTION.
Our proprietary 128-gene panels are built for one purpose: early, accurate diagnosis. Each gene is hand-selected for its proven link to disease onset, risk, or progression — delivering clear, clinical-grade insight.
KEY APPLICATIONS
Female Cancer Panels:
Detects breast, ovarian, cervical, and endometrial risk markers.
Male Cancer Panels:
Targets early indicators of prostate and testicular cancer.
Pancreatic Cancer:
One of the most difficult to detect. Caught earlier with molecular precision
These panels move beyond broad screening to provide
focused, high-value diagnostics that can guide real intervention
REAL-TIME mRNA TESTING
FROM RISK TO ACTIVITY. DETECTING WHAT'S HAPPENING NOW.
REAL-TIME mRNA TESTING
While DNA shows potential risk, mRNA reveals current biological activity. Our mRNA panels detect active gene expression tied to early disease. Even when patients feel healthy.
Isolated RNA abbreviation of ribonucleic acid. RNA typically is a single-stranded biopolymer.
Applications include:
AUTISM
Expression patterns linked to early neurodevelopmental
disruption.
HEART DISEASE
Inflammatory gene activity associated with pre-symptomatic cardiac risk.
ALZEIMER'S & DEMENTIAS
Early changes in brain-related gene expression, often years before symptoms.
This real-time insight makes our tests uniquely powerful, combining prediction with precision.
CURRENT PANELS ADDRESS:
Cancers:
Including breast, ovarian, prostate, testicular and pancreatic.
Neurodegenerative disease:
Alzheimer's, Parkinson's, and related dementias.
Chronic & Developmental Conditions:
Heart disease, autism, and more.
